Phibro Animal Health (PAHC) vs SIGA Technologies (SIGA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Phibro Animal Health (PAHC) has outperformed SIGA Technologies (SIGA) over the past year, gaining 3.0% versus a loss of 61.2%. Over five years, PAHC leads with a +75.7% price change compared with -53.9% for SIGA. Phibro Animal Health is the larger company by market cap ($1.56 billion vs $235.7 million), about 6.6 times the size.
On valuation, SIGA Technologies trades at a lower forward P/E (3.0x vs 10.0x for Phibro Animal Health). Phibro Animal Health pays a dividend yielding 1.25%, while SIGA Technologies does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PAHC | SIGA |
|---|---|---|
| Share price | $38.30 | $3.28 |
| Market cap | $1.56B | $235.67M |
| 1-day change | +2.41% | 0.00% |
| YTD return | +2.52% | -46.32% |
| 1-year return | +3.04% | -61.18% |
| 5-year return | +75.69% | -53.87% |
| P/E ratio (TTM) | 15.76 | — |
| Forward P/E | 9.97 | 3.04 |
| EPS (TTM) | $2.43 | $-0.04 |
| Dividend yield | 1.25% | 0.00% |
| Annual dividend | $0.48 | $0.00 |
| Revenue (latest FY) | $1.52B | — |
| Revenue growth (YoY) | +17.12% | — |
| Net income (latest FY) | $99.72M | — |
| Gross margin | 33.76% | — |
| Operating margin | 12.81% | — |
| Net margin | 6.57% | — |
| 52-week high | $60.08 | $8.55 |
| 52-week low | $28.25 | $2.83 |
| Distance from 52-week high | -36.25% | -61.64% |
| Analyst consensus | hold | none |
| Avg. price target upside | +14.88% | — |
| Average volume | 231.66K | 724.21K |
| Shares outstanding | 21.11M | 71.85M |
| Employees | 2,605 | 49 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Phibro Animal Health is about 6.6 times larger than SIGA Technologies by market value ($1.56B vs $235.67M).
- PAHC has outperformed SIGA by 64.2 percentage points over the past year.
- Phibro Animal Health offers a meaningfully higher dividend yield (1.25% vs 0.00%).
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
About SIGA Technologies
SIGA stock →SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
PAHC vs SIGA FAQ
Which is bigger, Phibro Animal Health or SIGA Technologies?
Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.56B compared with $235.67M for SIGA Technologies (SIGA).
Which stock has performed better over the past year, PAHC or SIGA?
PAHC returned +3.04% over the past 12 months, compared with -61.18% for SIGA (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Phibro Animal Health or SIGA Technologies?
Phibro Animal Health pays a dividend yielding 1.25%, while SIGA Technologies does not currently pay a regular dividend.
Are Phibro Animal Health and SIGA Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.